ZEB1 and cutaneous melanoma: In order to further investigate ZEB1 co-expression or antagonistic expression with markers of melanoma cell states in patient samples, we performed spatial multi-immunofluorescence analyses (7 colors, OPAL, Perkin-Elmer) in a cohort of 30 cutaneous melanomas, previously annotated for ZEB1 expression as low, int or high.